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Nonsense Mutations in SMPX, Encoding a Protein
Responsive to Physical Force, Result
in X-Chromosomal Hearing Loss
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Holger Thiele,4 Janine Altmu¨ller,4 Florian Wagner,7 Antonio Vin˜uela,2,3 Luis A. Aguirre,2,3
Felipe Moreno,2,3 Hannes Maier,8 Isabella Rau,9 Sebastian Gießelmann,1 Gudrun Nu¨rnberg,4,5,10
Andreas Gal,9 Peter Nu¨rnberg,4,5,7,10 Christian A. Hu¨bner,1 Ignacio del Castillo,2,3 and Ingo Kurth9,11,*
The fact that hereditary hearing loss is the most common sensory disorder in humans is reflected by, among other things, an extraor-
dinary allelic and nonallelic genetic heterogeneity. X-chromosomal hearing impairment represents only a minor fraction of all cases. In
a study of a Spanish family the locus for one of the X-chromosomal forms was assigned to Xp22 (DFNX4). We mapped the disease locus
in the same chromosomal region in a large German pedigree with X-chromosomal nonsyndromic hearing impairment by using
genome-wide linkage analysis. Males presented with postlingual hearing loss and onset at ages 3–7, whereas onset in female carriers
was in the second to third decades. Targeted DNA capture with high-throughput sequencing detected a nonsense mutation in the small
muscle protein, X-linked (SMPX) of affected individuals. We identified another nonsense mutation in SMPX in patients from the Spanish
family whowere previously analyzed tomapDFNX4. SMPX encodes an 88 amino acid, cytoskeleton-associated protein that is responsive
to mechanical stress. The presence of Smpx in hair cells and supporting cells of the murine cochlea indicates its role in the inner ear. The
nonsense mutations detected in the two families suggest a loss-of-function mechanism underlying this form of hearing impairment.
Results obtained after heterologous overexpression of SMPX proteins were compatible with this assumption. Because responsivity to
physical force is a characteristic feature of the protein, we propose that long-term maintenance of mechanically stressed inner-ear cells
critically depends on SMPX function.As the most common sensory disorder in humans, hearing
loss affects about 1 in 1000 newborns.1 It is assumed that
at least half of the cases have a genetic basis, and more
than two-thirds of this subset of cases are classified as non-
syndromic hearing loss (NSHL) because of the absence of
additional symptoms. The vast majority of NSHL is caused
by mutations in autosomal genes. X-chromosomal inheri-
tance accounts for only 1%–5% of the cases.2 To date, four
X-chromosomal NSHL loci (DFNX) have been mapped,
and two genes have been implicated in this group of disor-
ders (Hereditary Hearing Loss Homepage). X-linked
DFNX1 (formerly DFN2 [MIM 304500]) is characterized by
postlingualprogressivehearingimpairmentandhasatypical
age at onset between 5 and 15years formales and in thefifth
decade for females. The gene mutated in DFNX1,3 PRPS1
(MIM 311850), encodes phosphoribosyl pyrophosphate
synthetase 1, which participates in the nucleotide biosyn-
thesis pathway by catalyzing the reaction of ribose-5-phos-
phatewithATP. Its function in the inner ear remains elusive.
Apart from its contribution to NSHL, mutations in PRPS1
have also been implicated in PRS-I superactivity (MIM
300661), Charcot-Marie-Tooth disease type 5 (CMTX51University Hospital Jena, Institute of Human Genetics, Jena 07743, German
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The Ame[MIM 311070]), and Arts syndrome (MIM 301835), all of
which can be accompanied by hearing loss.4 POU3F4
(MIM300039) encodes amember of the POU family of tran-
scription factors and is mutated in DFNX2 (formerly DFN3
[MIM304400]),5 which is characterized by prelingual senso-
rineural deafness accompanied by a conductive component
because of stapedial fixation.
In the present study, we investigated a large German
pedigree with a postlingual NSHL for which age at onset
is 3–7 in males. Initially, there is a moderate hearing loss,
especially for high frequencies, that progresses with age
and affects all frequencies later. Onset of hearing loss in
female carriers is in the second to third decades, and
patients present with a severe hearing loss after 10–15
years (Figure 1). Vestibular function was normal, and
tinnitus was not reported by the affected individuals. No
signs of a conductive hearing loss-component (no air-
bone gaps) were noticed in pure-tone audiometry; this
finding indicates a normal middle-ear function. Computed
tomography, magnetic resonance imaging and digital
volume tomography showed a normal middle-ear cavity
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Figure 1. Clinical Phenotype and Segregation Analysis in a German Family Affected by Hereditary Hearing Loss
(A) Audiograms of selected family members (red indicates the right ear, and blue indicates the left ear). Hearing loss in males typically
starts between ages 3–7, whereas hearing loss in females begins in the second to third decades.
(B) Haplotypes constructed by four Xp22.12 SNP markers mapped the disease locus between rs1482816 (hg19 X: 5746140) and
rs1557901 (hg 19 X: 23222925). Individuals I-1–I-4, III-4, III-6, IV-1, and V-1 were not subjected to the 10K GeneChip linkage analysis.of malformation in the affected individuals. The regular
inner-ear structures had fluid-filled, normally shaped
cochlea that allowed later treatment by cochlear
implantation.
Genome-wide linkage analysis (GeneChip Human
Mapping 10K Array, Affymetrix, Santa Clara, CA, USA) on
11 affected family members revealed linkage to a 17.5 Mb
interval in Xp22.12 and maximum LOD scores of 2.23622 The American Journal of Human Genetics 88, 621–627, May 13,(Figure S1, available online). Analysis of multiple informa-
tive meioses assigned the disease locus between
rs1482816 (hg19 X: 5746140) and rs1557901 (hg19
X: 23222925) (Figure 1). We calculated LOD score by using
the ALLEGRO6 program and assumed dominant inheri-
tance with full penetrance and a disease allele frequency
of 0.0001. Haplotypes were reconstructed with MERLIN7
and presented graphically with HaploPainter.82011
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Figure 2. Identification of Nonsense Mutations in SMPX
(A) Sequencing of genomic DNA revealed the SMPX nonsense mutations c.109G>T in exon 3 in the German family (left) and c.175G>T
in exon 4 in the Spanish family14 (right). Electropherograms of a respective heterozygous female carrier and a hemizygous male are
shown in comparison to a reference sequence. No additional mutations have been identified in a cohort of 34 GJB2-negative individuals
with early-onset hearing loss.
(B) SMPX is composed of five exons (left, the coding sequence is given in blue) and encodes an 88 amino acid protein (right) without
known functional domains.To identify the gene mutated in the family, we per-
formed targeted enrichment of all exons and 1 kb of the
promoter regions of the 88 protein-coding genes and
known miRNAs within the critical interval (GRCh37/
hg19) by using the Roche NimbleGen 385K custom
sequence capture array. Final coverage of the design was
96.3% and included an offset of 100 bp. DNA of two
affected males from the family (individuals III-2 and III-5,
see Figure 1B) was subjected to target enrichment and
sequencing. We prepared the sequencing library by using
standard Illumina protocols including end repair;
A-tailing, paired-end adaptor ligation; and amplification
by PCR. Enrichment factors (284-fold and 280-fold) were
determined by quantitative PCR of four control loci in
the array in a comparison of enriched versus nonenriched
DNA. The two libraries were subjected to massively parallel
sequencing (Illumina GA IIx), resulting in approximately
2828.6 Mb and 2606.0 Mb of raw sequences for the two
individuals analyzed. For primary data analysis, a semiauto-
mated data-processing pipeline was established. We first
mapped reads to version hg19 of the human reference
genome by using the MAQ short-read alignment soft-
ware9 on a large-scale compute cluster. We called single-
nucleotide variants (SNVs) by using the MAQ downstreamThe Ameanalysis tools.9 For indel calling, we repeated the align-
ment procedure by using the BWA aligner10 and the SAM-
tools11 software for downstream analysis. A total of 3858
and 3443 X-chromosomal variants were called for individ-
uals III-2 and III-5 (Table S1).
At the same time, we collected DNA samples from addi-
tional affected males and genotyped them for highly poly-
morphic microsatellite markers; by doing this we reduced
the linkage region to ~8.5 Mb flanked by DXS987 (hg19
X:14709303) at the telomericend.Whenthe refined interval
(UCSC Genome Browser hg19 X:14709303-23223175) was
taken into account, the number of SNVs remaining was
398 and 347 for the respective patients (Tables S1 and S2).
Six variants located to exons and were not annotated as
SNPs. We considered these variants for their impact on
protein synthesis and the degree of evolutionary conserva-
tion by using GERP and PolyPhen.12,13 The nonsense muta-
tion c.109G>T (p.Glu37X) in small muscle protein, X-linked
(SMPX) (NM_014332.1, hg19 X:21761891) was considered
the best candidate for NSHL in view of the character of the
mutation and the GeneRIF entries and was confirmed by
Sanger sequencing (Figure 2A, left panel).
Remarkably, the candidate interval included DFNX4
(MIM 300066, formerly DFN6), the locus for one form ofrican Journal of Human Genetics 88, 621–627, May 13, 2011 623
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Figure 3. Heterologous Expression of the SMPX Mutant Proteins
(A) C-terminally Myc-tagged human SMPX (SMPX_myc) was overexpressed in HeLa cells. Costaining withMyc (Santa Cruz, A14 sc-789)
and vinculin antibodies (ChemikonMAB3574) revealed overlap, especially in the focal adhesion sites of the cell periphery. Enlargements
of the cell membrane (white rectangles) are given. Note that SMPX_myc was largely absent from themature focal adhesions that serve as
anchor points for actin stress fibers (right, arrowheads). The scale bar indicates 5mm.
(B) Truncated SMPX (SMPX_59X_myc) revealed an intracellular staining in HeLa cells; the signal was largely absent from adhesion sites
at the cell membrane, indicating partial mislocalization of the protein. Enlargements of the cell membrane (white rectangles) are given
on the right. SMPX_37X_myc, corresponding to the mutation identified in the German family, was not detectable with Myc antibodies
after heterologous expression in HeLa cells (not shown). The scale bar indicates 5mm.X-chromosomal NSHL mapped in a Spanish family.14 The
NSHL in this family was bilateral, symmetric, sensori-
neural, postlingual, and progressive. In affected males,
a high-frequency hearing loss was detected at age 5–7; by
adulthood, it had become severe or profound and involved
all frequencies. Females manifested a moderate hearing
impairment for the high frequencies, and onset was in
the fourth decade of life. Subsequent investigation of
SMPX in this family identified the nonsense mutation
c.175G>T (p.Gly59X) (hg19 X:21755773), which segre-
gated with the hearing loss (Figure 2A, right panel). Both
the c.109G>T and c.175G>T SMPX mutations (Figure 2B)
result in transcripts with premature stop codons and are
likely to undergo nonsense-mediated mRNA decay
(NMD), suggesting loss-of-function as the underlying
mechanism of the hearing impairment. These data demon-
strate that SMPX is the gene mutated in the DFNX4-associ-
ated disease. In an independent concurrent study of two
additional families with hearing loss, Schraders et al. (in
this issue) also identified mutations in SMPX and their
study provides additional support for our findings.15
Written informed consent was obtained from all the study
participants after approval from the Institutional Review
Boards at the participating institutions.
Human SMPX encodes a small 88-amino acid protein
(NP_055147.1) that has no known functional domains
andwas initially cloned frommuscle.16 SMPXwas also iden-624 The American Journal of Human Genetics 88, 621–627, May 13,tified in a screening for stretch-responsive skeletal muscle
genes and shown to be highly upregulated in response to
passive stretch in vivo.17 In adult striated myocytes, Smpx
localizes to costamere structures,18 muscle-specific protein
networks that couple the force-generating sarcomeres
with the sarcolemma and the surrounding extracellular
matrix. This functional unit acts as a buffer to protect the
sarcolemmal plasma membrane from damage generated
by themechanical stress of contractingmuscle cells. Costa-
meres are believed to represent a striated-muscle-specific
elaboration of focal adhesions in nonmuscle cells.19 These
dynamic protein complexes, through which the cytoskel-
eton of a cell connects to the extracellular matrix, are
mechanosensitive in that they respond to force by
changing their size, dynamics, and signaling activity.20 In
line with this, Smpx has been shown to partially colocalize
with focal adhesion complexes upon heterologous expres-
sion and precipitate with the focal adhesion marker vincu-
lin.21 In HeLa cells, heterologously expressed, C-terminally
Myc-tagged SMPX (SMPX_myc) showed a predominant
intracellular staining and enrichment in lamellipodia
(Figure 3). A partial overlap with vinculin was observed,
especially in adhesion complexes of the cell periphery. Of
note, SMPX_myc did not reveal a substantial overlap with
the mature focal adhesions that serve as anchor points for
actin stress fibers, and this implies a nonexclusive role for
the protein in adhesion processes. Staining of the truncated2011
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Figure 4. Localization of Smpx in the Mouse Inner Ear
(A) A schematic representation of the cochlea. The sensory epithelium is composed of inner hair cells (IHC) and outer hair cells (OHC).
Nonsensory supporting cells include Deiters cells (DC), Bo¨ttcher cells (BC), and inner and outer pillar cells (iPC, oPC). Root cells (RC)
build up a cellular network in the lateral wall of the cochlea.
(B) Cryosections (7-mm thickness) from the cochlea of adult C57BL/6J mice were stained with an Smpx antibody (Sigma Aldrich
#AV41597, 1:500, green), and DAPI (blue). The overlay with differential interference contrast is shown. The scale bar represents
25mm. Stainings of SMPX_myc overexpressing HeLa cells with the Smpx rabbit-antiserum gave the same signal as with the mouse
Myc-antibody (data not shown).
(C and D) Enlargements of spiral ligament cells and outer sulcus cells together with root cells (C) and the sensory epithelium with sup-
porting cells (D). Note the Smpx localization in root cells, Bo¨ttcher cells, inner and outer pillar cell, and weaker signals in Deiters cells and
hair cells (marked by arrows).
(E) Apical basilar membranes of fixed cochleae were dissected and immunostained with an Smpx antibody (green) and conjugated phal-
loidin (red). Weak Smpx immunoreactivity was detected in inner and outer hair cells. The scale bar indicates 5mm.variant SMPX_59X_myc (p.Gly59X in the Spanish family)
with the Myc antibody showed an intracellular signal
comparable to wild-type; however, absence of the protein
from the cell membrane and thus the vinculin-positive
cell periphery indicated partial mistargeting (Figure 3). No
specific staining was observed with the Myc antibody after
expression of the sequence-verified SMPX_37X_myc
variant (p.Glu37X, German family), indicating very low
abundance or rapid degradation of newly synthesized poly-
peptides. These results suggest that the SMPX transcripts
with early stop codons are degraded by NMD and represent
a functional null allele. Alternatively, transcripts can escape
NMD and produce largely truncated and misrouted, that is
nonfunctional, polypeptides.
Immunolocalization studies by an Smpx antibody and
longitudinal cross-sections of the mouse cochlea revealed
staining in different cell types, including Bo¨ttcher cells,
root cells, pillar cells, and interdental cells of the limbus
spiralis. Smpx immunoreactivity was also detected at low
levels in hair cells (Figure 4).
In thehearingprocess, the inductionof soundcausesfluid
tomove through the cochlear duct and thereby deflects theThe Amebasilar membrane with the sensory epithelium against the
tectorialmembrane.Thus, chronicmechanical stress is char-
acteristic for the inner ear. Themechanical forceonhair cells
leads to the transduction of sound into an electrical signal
that underlies the hearing process. The tips of hair cells are
equipped with mechanical-vibration-sensitive stereocilia
that enable mechanosensory transduction. Stereocilia are
arranged as a staircase and connected with lateral and tip
links on the basis of elaborate actin-based cellular protru-
sions. Indeed, a significant number of genes in which
variation is associated with deafness encode actin or actin-
binding proteins, motor proteins of the myosin family, or
proteins that are otherwise linked to the cytoskeleton.22,23
Given the association of SMPX with the cytoskeleton, the
responsivity to mechanical force, and the detection of
Smpx in hair cells in the mouse, it is tempting to speculate
that SMPXmight play a role in themaintenance of stereoci-
lia, which are permanently exposed to physical forces.
SMPX might also contribute to actin turnover and length
regulation in stereocilia because these features are tightly
regulated by extrinsic biomechanical forces.24 However,
the antibody stainings failed to show a selective labeling ofrican Journal of Human Genetics 88, 621–627, May 13, 2011 625
the stereociliar bundles of the inner and outer hair cells,
whichargues against highabundanceof Smpx in stereocilia.
Mechanotransduction is not limited to hair cells and is
crucial in the maintenance of many mechanically stressed
tissues.25 Hence, any changes in normal intracellular-force
transmission can result in altered mechanosensitive
signals and cellular dysfunction. In addition to hair cells,
physical force is also applied to other cells of the organ of
Corti. SMPX might play a protective role against mechan-
ical stress in different cell types of the organ of Corti, in
line with the observed expression pattern, and functional
loss of SMPX could lead to the progressive hearing impair-
ment in the affected individuals.
Despite its strong expression in muscle cells, SMPX
appears to be largely dispensable for muscle function
because patients from the families studied do not show
obvious signs of muscular dysfunction. Interestingly,
elevated creatine kinase levels (400 U/l) and myalgias
have been repeatedly reported in a 71-year-oldmale patient
from theGerman family; however, the relation to the SMPX
mutation is currently unclear. Mice with a targeted disrup-
tion of Smpx (named Csl) did not exhibit an overt muscle
phenotype.18 Breeding of the Csl knockout-mouse line
has been discontinued, and thus it is not available for
hearing tests (R.P. Harvey, personal communication).
Remarkably, defects in the Rac1/p38 pathway, which is
a target of Smpx,21 have also been shown to be associated
with inner-ear dysfunction. Rac1 belongs to the family of
small GTPases. It is activated by biomechanical stress,
upon which it is recruited to sites of actin reorganization
and integrin-mediated cell adhesions. Intriguingly, condi-
tional ablation of Rac1 in the otic epithelium of mice re-
sulted in defective morphogenesis of the auditory sensory
epithelium and stereociliary bundle.26 p38 has also been
shown to be of relevance for inner-ear function; inhibition
of p38 MAP kinase phosphorylation suspended genta-
micin-induced ototoxicity, a side effect of aminoglycoside
therapy leading to permanent hair-cell loss and hearing
impairment.27 Smpx is also stimulated by insulin-like
growth factor-1 (IGF-1).18 IGF-1 mutations in humans are
associated with syndromic sensorineural deafness28 and
Igf-1-null mice exhibit hearing loss.29
In conclusion, our study identified mutations in SMPX
in patients with X-chromosomal hearing impairment
and suggested that the stress response of mechanically
challenged inner-ear cells might critically depend on
SMPX function.Supplemental Data
Supplemental Data include one figure and two tables and can be
found with this article online at http://www.cell.com/AJHG/.Acknowledgments
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